Tailwinds for this company helping to treat COVID-19 patients, giving the stock 40% upside. Access the research in the new Capital Ideas Digest. Subscribers.

Or sign up for the free Morning Note. 

https://t.co/ddHbSNGBfV

#investingtips #investing101 #stocks @capitalideasr https://t.co/TFjfGCpivp